论文部分内容阅读
目的探讨和研究孕三烯酮对于子宫内膜异位症患者术后的临床疗效。方法选取苍山县妇幼保健院近年来行手术治疗子宫内膜异位症的66例患者资料作为研究对象,按照随机分组的原则将其分为观察组和对照组各33例,其中对照组单纯采用米非司酮进行治疗,观察组则在此基础上加用孕三烯酮进行治疗,治疗结束后进行随访统计两组患者缓解程度和复发率。结果观察组的总缓解率明显高于对照组,复发率明显低于对照组,差异具有统计学意义(P<0.05)。结论孕三烯酮联合米非司酮进行子宫内膜异位症术后的治疗效果显著,较单纯采用米非司酮有明显优势,值得在临床上加以推广和应用。
Objective To investigate and study the clinical efficacy of gestrinone in patients with endometriosis. Methods Cangshan County Maternal and Child Health Hospital in recent years, surgical treatment of endometriosis 66 cases of patients as the research object, according to the principle of randomized divided into observation group and control group of 33 cases, of which the control group simply adopted Mifepristone treatment, the observation group is based on this plus gestrinone treatment, follow-up after treatment statistics of the two groups of patients with remission and recurrence rate. Results The total remission rate of the observation group was significantly higher than that of the control group, the recurrence rate was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion Gestrinone combined with mifepristone has a significant therapeutic effect after endometriosis, which is obviously superior to that of mifepristone alone. It is worth to be popularized and applied clinically.